Oral therapy for Gaucher disease: Study yields positive results

Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a new study, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.

Read the whole article on Science Daily

More from Science Daily